Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 4, 2013, Pages 583-592

  Yun, Xiang ^a   Maximov, Victor D ^a   Yu, Jin ^b   Zhu, Hong ^b   Vertegel, Alexey A ^a   Kindy, Mark S ^a,b,c,d  

^a South   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

anti oxidants; antibody; cerebral ischemia; nanoparticles; superoxide dismutase

Indexed keywords

ANTIBODY; ANTIOXIDANT ENZYME; ENBUCRILATE; ENZYME; GLUCOSE; LIPOSOME; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NANOPARTICLE; OXYGEN; POLY(BUTYL 2 CYANOACRYLATE); POLYGLACTIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HIPPOCAMPUS; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; ANTIBODIES; ANTIOXIDANTS; APOPTOSIS; BIOLOGICAL MARKERS; BRAIN INFARCTION; DRUG DELIVERY SYSTEMS; ENZYMES, IMMOBILIZED; HIPPOCAMPUS; MICE; NANOPARTICLES; RECEPTORS, N-METHYL-D-ASPARTATE; REPERFUSION INJURY; STROKE; SUPEROXIDE DISMUTASE;

EID: 84876406479     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.209     Document Type: Article

References (49)

1. Borgens RB, Liu-Snyder P. Understanding secondary injury. Q Rev Biol 2012; 87: 89-127.
2. Tuttolomondo A, Di Sciacca R, Di Raimondo D, Arnao V, Renda C, Pinto A et al. Neuron protection as a therapeutic target in acute ischemic stroke. Curr Top Med Chem 2009; 9: 1317-1334.
3. Yang Y, Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 2011; 42: 3323-3328.
4. Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, Sakata H et al. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal 2011; 14: 1505-1517.
5. Allen CL, Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 2009; 4: 461-470.
6. Adibhatla RM, Hatcher JF. Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies. BMB Rep 2008; 41: 560-567.
7. Yu G, Hess DC, Borlongan CV. Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke. Brain Res 2004; 1018: 32-37.
8. Amador M, Guest J. An appraisal of ongoing experimental procedures in human spinal cord injury. J Neurol Phys Ther 2005; 29: 70-86.
9. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001; 21: 2-14.
10. Chan PH. Oxygen radicals in focal cerebral ischemia. Brain Pathol 1994; 4: 59-65.
11. Kontos HA, George E. Brown Memorial Lecture: oxygen radicals in cerebral vascular injury. Circ Res 1985; 57: 508-516.
12. Siesjö BK, Agardh CD, Bengtsson F. Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1989; 1: 165-211.
13. Francis JW, Ren J, Warren L, Brown Jr RH, Finklestein SP. Postischemic infusion of Cu/Zn superoxide dismutase or SOD:Tet451 reduces cerebral infarction following focal ischemia/reperfusion in rats. Exp Neurol 1997; 146: 435-443.
14. Pong K. Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics. Expert Opin Biol Ther 2003; 3: 127-139.
15. Saito A, Hayashi T, Okuno S, Nishi T, Chan PH. Modulation of the Omi/HtrA2 signaling pathway after transient focal cerebral ischemia in mouse brains that overexpress SOD1. Brain Res Mol Brain Res 2004; 127: 89-95.
16. Warner DS, Sheng H, Batinic-Haberle I. Oxidants, antioxidants and the ischemic brain. J Exp Biol 2004; 207: 3221-3231.
17. Liu TH, Beckman JS, Freeman BA, Hogan EL, Hsu CY. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol 1989; 256: H589-H593.
18. Matsumiya N, Koehler RC, Kirsch JR, Traystman RJ. Conjugated superoxide dis-mutase reduces extent of caudate injury after transient focal ischemia in cats. Stroke 1991; 22: 1193-1200.
19. Armstead WM, Mirro R, Thelin OP, Shibata M, Zuckerman SL, Shanklin DR et al. Polyethylene glycol superoxide dismutase and catalase attenuate increased blood-brain barrier permeability after ischemia in piglets. Stroke 1992; 23: 755-762.
20. Truelove D, Shuaib A, Ijaz S, Ishaqzay R, Kalra J. Neuronal protection with superoxide dismutase in repetitive forebrain ischemia in gerbils. Free Radic Biol Med 1994; 17: 445-450.
21. Veronese FM, Caliceti P, Schiavon O, Sergi M. Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation. Adv Drug Deliv Rev 2002; 54: 587-606.
22. Pun PB, Lu J, Moochhala S. Involvement of ROS in BBB dysfunction. Free Radic Res 2009; 43: 348-364.
23. Spatz M. Past and recent BBB studies with particular emphasis on changes in ischemic brain edema: dedicated to the memory of Dr Igor Klatzo. Acta Neurochir Suppl 2010; 106: 21-27.
24. Kuroiwa T, Ting P, Martinez H, Klatzo I. The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion. Acta Neuropathol 1985; 68: 122-129.
25. Klatzo I. Brain oedema following brain ischaemia and the influence of therapy. Br J Anaesth 1985; 57: 18-22.
26. Klatzo I. Blood-brain barrier and ischaemic brain oedema. Z Kardiol 1987; 76: 67-69.
27. Reddy MK, Wu L, Kou W, Ghorpade A, Labhasetwar V. Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress. Appl Biochem Biotech 2008; 151: 565-577.
28. Reddy MK, Labhasetwar V. Nanoparticle-mediated delivery of superoxide dis-mutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J 2009; 23: 1384-1395.
29. Lin Y, Pan Y, Shi Y, Huang X, Jia N, Jiang JY. Delivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brain. Nanotechnology 2012; 23: 165101.
30. Begley DJ. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Therap 2004; 104: 29-45.
31. Reukov V, Maximov V, Vertegel A. Proteins conjugated to poly(butyl cyanoacry-late) nanoparticles as potential neuroprotective agents. Biotech Bioeng 2010; 108: 243-252.
32. Hantel C, Lewrick F, Reincke M, Süss R, Beuschlein F. Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma. J Endocrinol 2012; 213: 155-161.
33. Lopes de Menezes DE, Pilarski LM, Allen TM. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Cancer Res 1998; 58: 3320-3330.
34. Moussaieff A, Yu J, Zhu H, Gattoni-Celli S, Shohami E, Kindy MS. Protective effects of incensole acetate on cerebral ischemic injury. Brain Res 2012; 1443: 89-97.
35. Yu J, Zhu H, Ko D, Kindy MS. Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse. Brain Res 2008; 1238: 143-153.
36. Mattson MP, Zhu H, Yu J, Kindy MS. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis. J Neurosci 2000; 20: 1358-1364.
37. Ellsworth JL, Garcia R, Yu J, Kindy MS. Time window of fibroblast growth factor-18-mediated neuroprotection after occlusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab 2004; 24: 114-123.
38. Bromont C, Marie C, Bralet J. Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats. Stroke 1989; 20: 918-924.
39. Lebel CP, Bondy SC. Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem Int 1990; 17: 435-440.
40. Driver AS, Kodavanti PR, Mundy WR. Age-related changes in reactive oxygen species production in rat brain homogenates. Neurotoxicol Teratol 2000; 22: 175-181.
41. Chan PH, Kinouchi H, Epstein CJ, Carlson E, Chen SF, Imaizumi S et al. Role of superoxide dismutase in ischemic brain injury: reduction of edema and infarction in transgenic mice following focal cerebral ischemia. Prog Brain Res 1993; 96: 97-104.
42. Chan PH, Kawase M, Murakami K, Chen SF, Li Y, Calagui B et al. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J Neurosci 1998; 18: 8292-8299.
43. Kondo T, Reaume AG, Huang T-T, Carlson E, Murakami K, Chen SF et al. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci 1997; 17: 4180-4189.
44. Kondo T, Reaume AG, Huang TT, Murakami K, Carlson E, Chen S et al. Edema formation exacerbates neurological and histological outcomes after focal cerebral ischemia in CuZn-superoxide dismutase gene knockout mutant mice. Acta Neu-rochir 1997; 70(Suppl): 62-64.
45. He YY, Hsu CY, Ezrin AM, Miller MS. Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia-reperfusion. Am J Physiol 1993; 265: H252-H256.
46. Chan PH, Longar S, Fishman RA. Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann Neurol 1987; 21: 540-547.
47. Imaizumi S, Woolworth V, Fishman RA, Chan PH. Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke 1990; 21: 1312-1317.
48. Genovese T, Cuzzocrea S. Role of free radicals and poly(ADP-ribose) polymerase-1 in the development of spinal cord injury: new therapeutic targets. Curr Med Chem 2008; 15: 477-487.
49. Lynch I, Dawson K. Protein-nanoparticle interactions. Nanotoday 2008; 3: 40-47.